norethindrone acetate has been researched along with Coronary Artery Disease in 1 studies
norethisterone acetate : A 3-oxo Delta(4)-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Falkeborn, M | 1 |
| Lithell, H | 1 |
| Persson, I | 1 |
| Vessby, B | 1 |
| Naessén, T | 1 |
1 trial available for norethindrone acetate and Coronary Artery Disease
| Article | Year |
|---|---|
Lipids and antioxidative effects of estradiol and sequential norethisterone acetate treatment in a 3-month randomized controlled trial.
Topics: Administration, Oral; Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Apoprotein(a); Cholest | 2002 |